This $1,432,794 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports gene expression analysis research on circulating tumor cells to develop a biomarker that can predict immunotherapy response in metastatic clear cell renal cell carcinoma. The award to Vanderbilt University Medical Center (VUMC) will fund this 4-year research project from September 2024 through September 2028. As a leading academic medical center, VUMC will leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care through this federally-funded initiative.
Generated 1/28/25, 11:07 AM